Importance of a N-terminal aspartate in the internalization of the neuropeptide Y Y2 receptor

European Journal of Pharmacology

Volumn 594, Issue 1-3, 2008, Pages 26-31

  Parker, Steven L ^a   Parker, Michael S ^b   Wong, Ying Y ^a   Sah, Renu ^c   Balasubramaniam, Ambikaipakan ^c   Sallee, Floyd ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Aspartate; Compartmentalization; Receptor cycling; Receptor endocytosis; Receptor masking

Indexed keywords

ALANINE; ASPARTIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y Y2 RECEPTOR; PROLINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CHO CELL; DIMERIZATION; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY;

AMINO ACID SEQUENCE; ANIMALS; ASPARTIC ACID; BINDING SITES; CHO CELLS; CRICETINAE; CRICETULUS; DNA PRIMERS; GTP-BINDING PROTEINS; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BINDING; RECEPTORS, NEUROPEPTIDE Y;

EID: 50549102892     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.07.038     Document Type: Article

References (38)

1. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., Wren A.M., Brynes A.E., Low M.J., Ghatei M.A., Cone R.D., and Bloom S.R. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418 (2002) 650-654
2. Berglund M.M., Schober D.A., Esterman M.A., and Gehlert D.R. Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. J. Pharmacol. Exp. Ther. 307 (2003) 1120-1126
3. Berglund M.M., Schober D.A., Statnick M.A., McDonald P.H., and Gehlert D.R. The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction. J. Pharmacol. Exp. Ther. 306 (2003) 147-156
4. Blanchard S.G., Chang K.J., and Cuatrecasas P. Characterization of the association of tritiated enkephalin with neuroblastoma cells under conditions optimal for receptor down regulation. J. Biol. Chem. 258 (1983) 1092-1097
5. Blanpain C., Doranz B.J., Vakili J., Rucker J., Govaerts C., Baik S.S., Lorthioir O., Migeotte I., Libert F., Baleux F., Vassart G., Doms R.W., and Parmentier M. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein. J. Biol. Chem. 274 (1999) 34719-34727
6. Bohme I., Morl K., Bamming D., Meyer C., and Beck-Sickinger A.G. Tracking of human Y receptors in living cells-A fluorescence approach. Peptides 28 (2007) 226-234
7. Boura-Halfon S., Voliovitch H., Feinstein R., Paz K., and Zick Y. Extracellular matrix proteins modulate endocytosis of the insulin receptor. J. Biol. Chem. 278 (2003) 16397-16404
8. Dautzenberg F.M., and Neysari S. Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors. Pharmacology 75 (2005) 21-29
9. Ekstrand A.J., Cao R., Bjorndahl M., Nystrom S., Jonsson-Rylander A.C., Hassani H., Hallberg B., Nordlander M., and Cao Y. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6033-6038
10. Frerker N., Wagner L., Wolf R., Heiser U., Hoffmann T., Rahfeld J.U., Schade J., Karl T., Naim H.Y., Alfalah M., Demuth H.U., and von Horsten S. Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4. Peptides 28 (2007) 257-268
11. Gicquiaux H., Lecat S., Gaire M., Dieterlen A., Mely Y., Takeda K., Bucher B., and Galzi J.L. Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor. J. Biol. Chem. 277 (2002) 6645-6655
12. Golbik R., Eble J.A., Ries A., and Kuhn K. The spatial orientation of the essential amino acid residues arginine and aspartate within the alpha1beta1 integrin recognition site of collagen IV has been resolved using fluorescence resonance energy transfer. J. Mol. Biol. 297 (2000) 501-509
13. Jackson S.N., Wang H.Y., Yergey A., and Woods A.S. Phosphate stabilization of intermolecular interactions. J. Proteome Res. 5 (2006) 122-126
14. Kamata T., Wright R., and Takada Y. Critical threonine and aspartic acid residues within the I domains of beta 2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi. J. Biol. Chem. 270 (1995) 12531-12535
15. Kauf A.C., Hough S.M., and Bowditch R.D. Recognition of fibronectin by the platelet integrin alpha IIb beta 3 involves an extended interface with multiple electrostatic interactions. Biochemistry 40 (2001) 9159-9166
16. Kuo L.E., Kitlinska J.B., Tilan J.U., Li L., Baker S.B., Johnson M.D., Lee E.W., Burnett M.S., Fricke S.T., Kvetnansky R., Herzog H., and Zukowska Z. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med. 13 (2007) 803-811
17. Ma L., Conrad P.J., Webb D.L., and Blue M.L. Aspartate 698 within a novel cation binding motif in alpha 4 integrin is required for cell adhesion. J. Biol. Chem. 270 (1995) 18401-18407
18. McLean A.J., and Milligan G. Ligand regulation of green fluorescent protein-tagged forms of the human beta(1)- and beta(2)-adrenoceptors; comparisons with the unmodified receptors. Br. J. Pharmacol. 130 (2000) 1825-1832
19. McMillan D.R., Kayes-Wandover K.M., Richardson J.A., and White P.C. Very large G protein-coupled receptor-1, the largest known cell surface protein, is highly expressed in the developing central nervous system. J. Biol. Chem. 277 (2002) 785-792
20. Munson P.J., and Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding proteins. Anal. Biochem. 107 (1980) 220-239
21. Naito M., Fukuda T., Sekiguchi K., and Yamada T. The domains of human fibronectin mediating the binding of alpha antigen, the most immunopotent antigen of mycobacteria that induces protective immunity against mycobacterial infection. Biochem. J. 347 Pt 3 (2000) 725-731
22. Parker M.S., Sah R., Sheriff S., Balasubramaniam A., and Parker S.L. Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonists. Regul. Pept. 132 (2005) 91-101
23. Parker S.L., and Balasubramaniam A. Neuropeptide Y Y2 receptor in health and disease. Br. J. Pharmacol. 153 (2008) 420-431
24. Parker S.L., Kane J.K., Parker M.S., Berglund M.M., Lundell I.A., and Li M.D. Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor. Eur. J. Biochem. 268 (2001) 877-886
25. Parker S.L., Parker M.S., Kane J.K., and Berglund M.M. A pool of Y2 neuropeptide Y receptors activated by modifiers of membrane sulfhydryl or cholesterol balance. Eur. J. Biochem. 269 (2002) 2315-2322
26. Parker S.L., Parker M.S., Lundell I., Balasubramaniam A., Buschauer A., Kane J.K., Yalcin A., and Berglund M.M. Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells shows strong preference for NPY, endosome-linked entry and fast receptor recycling. Regul. Pept. 107 (2002) 49-62
27. Parker S.L., Parker M.S., Sah R., Balasubramaniam A., and Sallee F.R. Self-regulation of agonist activity at the Y receptors. Peptides 28 (2007) 203-213
28. Parker S.L., Parker M.S., Sah R., Balasubramaniam A., and Sallee F.R. Pertussis toxin induces parallel loss of neuropeptide Y Y(1) receptor dimers and G(i) alpha subunit function in CHO cells. Eur. J. Pharmacol. 579 (2008) 13-25
29. Parker S.L., Parker M.S., Sah R., and Sallee F. Angiogenesis and rhodopsin-like receptors: A role for N-terminal acidic residues?. Biochem. Biophys. Res. Commun. 335 (2005) 983-992
30. Parker S.L., Parker M.S., Sah R., Sallee F.R., and Balasubramaniam A. Parallel inactivation of Y2 receptor and G-proteins in CHO cells by pertussis toxin. Regul. Pept. 139 (2007) 128-135
31. Parker S.L., Parker M.S., Sallee F.R., and Balasubramaniam A. Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins. Regul. Pept. 144 (2007) 72-81
32. Proudfoot A.E., Fritchley S., Borlat F., Shaw J.P., Vilbois F., Zwahlen C., Trkola A., Marchant D., Clapham P.R., and Wells T.N. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276 (2001) 10620-10626
33. Rieu P., Sugimori T., Griffith D.L., and Arnaout M.A. Solvent-accessible residues on the metal ion-dependent adhesion site face of integrin CR3 mediate its binding to the neutrophil inhibitory factor. J. Biol. Chem. 271 (1996) 15858-15861
34. Rose P.M., Fernandes P., Lynch J.S., Frazier S.T., Fisher S.M., Kodukula K., Kienzle B., and Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem. 270 (1995) 22661-22664
35. Sheikh S.P., Sheikh M.I., and Schwartz T.W. Y2-type receptors for peptide YY on renal proximal tubular cells in the rabbit. Am. J. Physiol. 257 (1989) F978-F984
36. Tu B., Timofeeva O., Jiao Y., and Nadler J.V. Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain. J. Neurosci. 25 (2005) 1718-1729
37. Zhou N., Zhang X., Fan X., Argyris E., Fang J., Acheampong E., DuBois G.C., and Pomerantz R.J. The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity. Virology 317 (2003) 84-94
38. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Fisher T.A., and Ji H. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul. Pept. 75-76 (1998) 231-238